Oxford Biomedica plc (OXB) Ordinary 50p
Sell:652.00pBuy:653.00p
3.00p
(0.46%)
FTSE techMARK 100:
0.29%
0.29%Market closed |
Prices delayed by at least 15 minutes
- This stock can be held in a
Create an alert
Stocks and Shares ISASell:652.00p
Buy:653.00p
Change:3.00p
(0.46%)
3.00p
(0.46%)Market closed |
Prices delayed by at least 15 minutes
Sell:652.00p
Buy:653.00p
Change:3.00p
(0.46%)
3.00p
(0.46%)Market closed |
Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 20 October 2025 | Heather Elizabeth PrestonNon-Executive Director | Buy Regular purchase transaction | 6,175 | £5.93 | £36,632.57 | 35,862 |
| 20 October 2025 | Kyriacos MitrophanousChief Level Officer | Sell Option/Award related | 26,210 | £5.76 | £150,927.03 | 724 |
| 15 October 2025 | Natalie Louise WalterGeneral Counsel | Sell Option/Award related | 68,000 | £6.12 | £415,947.57 | 1,754 |
| 18 August 2025 | Kay DaviesIndependent Director | Sell Regular sell transaction (market) | 4,563 | £5.00 | £22,833.34 | 1,000 |
| 15 August 2025 | Frederic Roch DoliveuxChairman of the Board | Buy Regular purchase transaction | 67,000 | £4.50 | £301,332.50 | 438,805 |
| 11 August 2025 | Kay DaviesIndependent Director | Buy Regular purchase transaction | 4,563 | £4.36 | £19,894.68 | 5,563 |
| 17 June 2025 | Heather Elizabeth PrestonNon-Executive Director | Buy Regular purchase transaction | 11,389 | £3.24 | £36,900.36 | 29,687 |
| 30 April 2025 | Kyriacos MitrophanousChief Level Officer | Sell Option/Award related | 1,209 | £2.98 | £3,601.01 | 724 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 15 October 2025 | Natalie Louise WalterGeneral Counsel | Sell Option/Award related | 68,000 | £6.12 | £415,947.57 | 1,754 |
| 15 August 2025 | Frederic Roch DoliveuxChairman of the Board | Buy Regular purchase transaction | 67,000 | £4.50 | £301,332.50 | 438,805 |
| 20 October 2025 | Kyriacos MitrophanousChief Level Officer | Sell Option/Award related | 26,210 | £5.76 | £150,927.03 | 724 |
| 17 June 2025 | Heather Elizabeth PrestonNon-Executive Director | Buy Regular purchase transaction | 11,389 | £3.24 | £36,900.36 | 29,687 |
| 20 October 2025 | Heather Elizabeth PrestonNon-Executive Director | Buy Regular purchase transaction | 6,175 | £5.93 | £36,632.57 | 35,862 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.